( November 13, 2024, 11:10 AM EST) -- BROOKLYN, N.Y. — The New York federal judge overseeing the multidistrict litigation stemming from allegations that over-the-counter cough and cold medications containing the active ingredient phenylephrine XE "phenylephrine" (PE) are ineffective at relieving nasal congestion dismissed all claims with prejudice on Nov. 12, rejecting a request by the plaintiffs to hold off granting the parties’ proposed order to dismiss all cases in light of a recent recommendation from the U.S. Food and Drug Administration....